Myomo (MYO) Net Income towards Common Stockholders Growth (3y) (2019 - 2025)
Powered by 
Analysis
Myomo (MYO) Net Income towards Common Stockholders Growth (3y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 22.97% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 51.47% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -7.83% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 29.05% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 17.54% |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -8.98% |
| Jun 30, 2025 | -16.77% |
| Mar 31, 2025 | -7.17% |
| Dec 31, 2024 | 27.85% |
| Sep 30, 2024 | 22.26% |
| Jun 30, 2024 | 24.65% |
| Mar 31, 2024 | -9.01% |
| Dec 31, 2023 | -23.32% |
| Sep 30, 2023 | 9.93% |
| Jun 30, 2023 | 32.43% |
| Mar 31, 2023 | 16.07% |
| Dec 31, 2022 | 5.26% |
| Sep 30, 2022 | -0.49% |
| Jun 30, 2022 | -4.28% |
| Mar 31, 2022 | 6.06% |
| Dec 31, 2021 | -7.81% |
| Sep 30, 2021 | 8.09% |
| Jun 30, 2021 | 0.10% |
| Mar 31, 2021 | -8.08% |
| Dec 31, 2020 | 3.67% |